Sanofi’s HERCULES Data In MS May Offer Path To Approval For Tolebrutinib

 
• By Joseph Haas
  
Man with Multiple Sclerosis standing in his accessible kitchen with a cane
Sanofi's drug may address progressing disability related to MS • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D